Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy.
[Therapy adherence to immunomodulator treatment in patients with multiple sclerosis].
MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis.
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab.
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study.
Functional Homotopic Changes in Multiple Sclerosis with Resting-State Functional MR Imaging.
[An update on the treatment options for multiple sclerosis].
Multiple sclerosis: Monotherapy rules.
VLA4 Gene Polymorphism and Susceptibility to Multiple Sclerosis in Slovaks.
Second generation S1P pathway modulators: Research strategies and clinical developments.
Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunction.
Contextualized perceptions of movement as a source of expanded insight: People with multiple sclerosis' experience with physiotherapy.
The effectiveness of fingolimod in a Portuguese real-world population.
Treadmill Training or Progressive Strength Training to Improve Walking in People with Multiple Sclerosis? A Randomized Parallel Group Trial.
Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler.
Reduced Dual-Task Performance in MS Patients Is Further Decreased by Muscle Fatigue.
Interest in providing multiple sclerosis care and subspecializing in multiple sclerosis among neurology residents.
The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
The genetics of multiple sclerosis: review of current and emerging candidates.
Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15.
Effects of different focus of attention rehabilitative training on gait performance in Multiple Sclerosis patients.
Cognitive Trajectories in 4 Patients With Pediatric-Onset Multiple Sclerosis: Serial Evaluation Over a Decade.
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.
Pages
« first
‹ previous
…
291
292
293
294
295
296
297
298
299
…
next ›
last »